FLUZONE HIGH DOSE NORTHERN HEMISPHERE

Sanofi Pasteur Inc.🇺🇸 United States

FDA Page

Effective Date: Jun 26, 2026
Approval ID: de0e2089-f781-4d47-99f5-c2a1b7b0f1eb
Products: 1 registered
Version: 7

Regulatory Information

Labeling Type

VACCINE LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use Fluzone High-Dose safely and effectively. See full prescribing information for Fluzone High-Dose. Fluzone High-Dose (Influenza Vaccine) injectable suspension, for intramuscular use 2026–2027 Formula Initial U.S. Approval: 2009

Quick Stats

Total Products1

Labelers2

Label Sections20

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.